Natural cures for type 1 diabetes: A review of phytochemicals, biological actions, and clinical potential

Current Medicinal Chemistry

Volumn 20, Issue 7, 2013, Pages 899-907

  Chang, C L T ^a   Chen, Yi Ching ^b   Chen, Hui Ming ^b,c   Yang, Ning Sun ^b   Yang, Wen Chin ^a,b,c,d  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b AGRICULTURAL BIOTECHNOLOGY RESEARCH CENTER   (Taiwan)

^c NATIONAL YANG MING UNIVERSITY   (Taiwan)

^d NATIONAL TAIWAN UNIVERSITY   (Taiwan)

Author keywords

And type 1 diabetes; Combination therapy; Immunotherapy; Insulin; Mechanism; Pancreatic cells; Phytochemicals; Replacement therapy

Indexed keywords

ANTHRAQUINONE; BERBERINE; BIDENS PILOSA EXTRACT; CANNABIDIOL; CANNABINOID; CAPSAICIN; CARCIA PAPAYA PLANT EXTRACT; CHINESE TEA; CONOPHYLLINE; CYTOPILOYNE; EPIGALLOCATECHIN GALLATE; GINSENG EXTRACT; GINSENOSIDE; KINSENOSIDE; MCS 18; NICOTINAMIDE; NYMPHAYOL; OLEA EUROPAEA PLANT EXTRACT; PANDANUS AMARYFOLLIUS PLANT EXTRACT; PLANT EXTRACT; PLANT MEDICINAL PRODUCT; POLYSACCHARIDE; PSACALIUM PELTATUM PLANT EXTRACT; RESVERATROL; SILYMARIN; TRIPTERYGIUM WILFORDII EXTRACT; UNCLASSIFIED DRUG;

ANOECTOCHILUS ROXBURGHII; ANTIDIABETIC ACTIVITY; ASTRAGALUS BISUCATUS; BERBERIS VULGARIS; BIDENS PILOSA; BONE MARROW CELL; CARCIA PAPAYA; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DIFFERENTIATION; DISEASE COURSE; DRUG MECHANISM; ENVIRONMENTAL FACTOR; GINSENG; GLUCOSE BLOOD LEVEL; HEREDITY; HUMAN; IMMUNOCOMPETENT CELL; IMMUNOMODULATION; INSULIN DEPENDENT DIABETES MELLITUS; MEDICINAL PLANT; NONHUMAN; NYMPHAEA STELLATA; OLIVE TREE; PANCREAS ISLET BETA CELL; PANDANUS AMARYFOLLIUS; PEPPER; PHYTOCHEMISTRY; POLYGONUM CUSPIDATUM; PSACALIUM PELTATUM; REVIEW; TABERNAEMONTANA DIVARICATA; TRIPTERYGIUM WILFORDII;

EID: 84877952183     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986713805219109     Document Type: Review

References (106)

1. The inflammation and disease connection. Mayo Clin. Womens Healthsource, 2005, 9, (4), 4-5.
2. Ermann, J.; Fathman, C.G., Autoimmune diseases: genes, bugs and failed regulation. Nat. Immunol., 2001, 2, (9), 759-761.
3. Youinou, P.; Pers, J.O.; Gershwin, M.E.; Shoenfeld, Y., Geo-epidemiology and autoimmunity. J. Autoimmun., 2010, 34, (3), J163-167.
4. Muntoni, S.; Cocco, P.; Aru, G.; Cucca, F., Nutritional factors and worldwide incidence of childhood type 1 diabetes. Am. J. Clin. Nutr., 2000, 71, (6), 1525-1529. (Pubitemid 30395900)
5. Mueller, D.B.; Koczwara, K.; Mueller, A.S.; Pallauf, J.; Ziegler, A.G.; Bonifacio, E., Influence of early nutritional components on the development of murine autoimmune diabetes. Ann. Nutr. Metab., 2009, 54, (3), 208-217.
6. Rees, D.A.; Alcolado, J.C., Animal models of diabetes mellitus. Diabet. Med., 2005, 22, (4), 359-370. (Pubitemid 40516231)
7. Anderson, M.S.; Bluestone, J.A., The NOD mouse: a model of immune dysregulation. Annu. Rev. Immunol., 2005, 23, 447-485. (Pubitemid 40563177)
8. Roep, B.O.; Atkinson, M.; von Herrath, M., Satisfaction (not) guaranteed: reevaluating the use of animal models of type 1 diabetes. Nat. Rev. Immunol., 2004, 4, (12), 989-997. (Pubitemid 39620073)
9. Kikutani, H.; Makino, S., The murine autoimmune diabetes model: NOD and related strains. Adv. Immunol., 1992, 51, 285-322.
10. Atkinson, M.A.; Leiter, E.H., The NOD mouse model of type 1 diabetes: as good as it gets? Nat. Med., 1999, 5, (6), 601-604. (Pubitemid 29289413)
11. Cha, T.L.; Qiu, L.; Chen, C.T.; Wen, Y.; Hung, M.C., Emodin downregulates androgen receptor and inhibits prostate cancer cell growth. Cancer Res., 2005, 65, (6), 2287-2295. (Pubitemid 40490138)
12. Eizirik, D.L.; Colli, M.L.; Ortis, F., The role of inflammation in insulitis and beta-cell loss in type 1 diabetes. Nat. Rev. Endocrinol., 2009, 5, (4), 219-226.
13. O'Reilly, L.A.; Hutchings, P.R.; Crocker, P.R.; Simpson, E.; Lund, T.; Kioussis, D.; Takei, F.; Baird, J.; Cooke, A., Characterization of pancreatic islet cell infiltrates in NOD mice: effect of cell transfer and transgene expression. Eur. J. Immunol., 1991, 21, (5), 1171-1180.
14. Lodoen, M.; Ogasawara, K.; Hamerman, J.A.; Arase, H.; Houchins, J.P.; Mocarski, E.S.; Lanier, L.L., NKG2D-mediated natural killer cell protection against cytomegalovirus is impaired by viral gp40 modulation of retinoic acid early inducible 1 gene molecules. J. Exp. Med., 2003, 197, (10), 1245-1253. (Pubitemid 36617771)
15. Richardson, S.J.; Willcox, A.; Bone, A.J.; Morgan, N.G.; Foulis, A.K., Immunopathology of the human pancreas in type 1 diabetes. Semin. Immunopathol., 2011, 33, (1), 9-21.
16. Saxena, V.; Ondr, J.K.; Magnusen, A.F.; Munn, D.H.; Katz, J.D., The countervailing actions of myeloid and plasmacytoid dendritic cells control autoimmune diabetes in the nonobese diabetic mouse. J. Immunol., 2007, 179, (8), 5041-5053.
17. Parsa, R.; Andresen, P.; Gillett, A.; Mia, S.; Zhang, X.M.; Mayans, S.; Holmberg, D.; Harris, R.A., Adoptive Transfer of Immunomodulatory M2 Macrophages Prevents Type 1 Diabetes in NOD Mice. Diabetes, 2012.
18. Gianani, R., Beta cell regeneration in human pancreas. Semin. Immunopathol., 2011, 33, (1), 23-27.
19. Szabat, M.; Lynn, F.C.; Hoffman, B.G.; Kieffer, T.J.; Allan, D.W.; Johnson, J.D., Maintenance of beta-cell maturity and plasticity in the adult pancreas: developmental biology concepts in adult physiology. Diabetes, 2012, 61, (6), 1365-1371.
20. Ackermann, A.M.; Gannon, M., Molecular regulation of pancreatic beta-cell mass development, maintenance, and expansion. J. Mol. Endocrinol., 2007, 38, (1-2), 193-206. (Pubitemid 46351603)
21. Waldron-Lynch, F.; Herold, K.C., Immunomodulatory therapy to preserve pancreatic beta-cell function in type 1 diabetes. Nat. Rev. Drug Discov., 2011, 10, (6), 439-452.
22. Ganesan, A., The impact of natural products upon modern drug discovery. Curr. Opin. Chem. Biol., 2008, 12, (3), 306-317.
23. Kim, H.Y.; Kim, K., Protective effect of ginseng on cytokine-induced apoptosis in pancreatic beta-cells. J. Agric. Food Chem., 2007, 55, (8), 2816-2823. (Pubitemid 46668283)
24. Zhang, Y.; Cai, J.; Ruan, H.; Pi, H.; Wu, J., Antihyperglycemic activity of kinsenoside, a high yielding constituent from Anoectochilus roxburghii in streptozotocin diabetic rats. J. Ethnopharmacol., 2007, 114, (2), 141-145. (Pubitemid 47539815)
25. Chueh, W.H.; Lin, J.Y., Berberine, an isoquinoline alkaloid in herbal plants, protects pancreatic islets and serum lipids in nonobese diabetic mice. J. Agric. Food Chem., 2011, 59, (14), 8021-8027.
26. Chueh, W.H.; Lin, J.Y., Protective effect of berberine on serum glucose levels in non-obese diabetic mice. Int. Immunopharmacol., 2012, 12, (3), 534-538.
27. Meng, F.; Abedini, A.; Plesner, A.; Verchere, C.B.; Raleigh, D.P., The flavanol (-)-epigallocatechin 3-gallate inhibits amyloid formation by islet amyloid polypeptide, disaggregates amyloid fibrils, and protects cultured cells against IAPP-induced toxicity. Biochemistry, 2010, 49, (37), 8127-8133.
28. Kawakami, M.; Hirayama, A.; Tsuchiya, K.; Ohgawara, H.; Nakamura, M.; Umezawa, K., Promotion of beta-cell differentiation by the alkaloid conophylline in porcine pancreatic endocrine cells. Biomed. Pharmacother., 2010, 64, (3), 226-231.
29. Ogata, T.; Li, L.; Yamada, S.; Yamamoto, Y.; Tanaka, Y.; Takei, I.; Umezawa, K.; Kojima, I., Promotion of beta-cell differentiation by conophylline in fetal and neonatal rat pancreas. Diabetes, 2004, 53, (10), 2596-2602. (Pubitemid 39299267)
30. Saito, R.; Yamada, S.; Yamamoto, Y.; Kodera, T.; Hara, A.; Tanaka, Y.; Kimura, F.; Takei, I.; Umezawa, K.; Kojima, I., Conophylline suppresses pancreatic stellate cells and improves islet fibrosis in Goto-Kakizaki rats. Endocrinology, 2012, 153, (2), 621-630.
31. Otonkoski, T.; Beattie, G.M.; Mally, M.I.; Ricordi, C.; Hayek, A., Nicotinamide is a potent inducer of endocrine differentiation in cultured human fetal pancreatic cells. J. Clin. Invest., 1993, 92, (3), 1459-1466. (Pubitemid 23273925)
32. Vaca, P.; Berna, G.; Araujo, R.; Carneiro, E.M.; Bedoya, F.J.; Soria, B.; Martin, F., Nicotinamide induces differentiation of embryonic stem cells into insulin-secreting cells. Exp. Cell Res., 2008, 314, (5), 969-974.
33. Subash-Babu, P.; Ignacimuthu, S.; Agastian, P.; Varghese, B., Partial regeneration of beta-cells in the islets of Langerhans by Nymphayol a sterol isolated from Nymphaea stellata (Willd.) flowers. Bioorg. Med. Chem., 2009, 17, (7), 2864-2870.
34. Shen, M.Y.; Lin, Y.P.; Yang, B.C.; Jang, Y.S.; Chiang, C.K.; Mettling, C.; Chen, Z.W.; Sheu, J.R.; Chang, C.L.; Lin, Y.L.; Yang, W.C., Catenarin prevents type 1 diabetes in nonobese diabetic mice via inhibition of leukocyte migration involving the MEK6/p38 and MEK7/JNK pathways. eCAM, 2012, 2012, 982396.
35. Hegde, V.L.; Nagarkatti, M.; Nagarkatti, P.S., Cannabinoid receptor activation leads to massive mobilization of myeloid-derived suppressor cells with potent immunosuppressive properties. Eur. J. Immunol., 2010, 40, (12), 3358-3371.
36. Lombard, C.; Nagarkatti, M.; Nagarkatti, P., CB2 cannabinoid receptor agonist, JWH-015, triggers apoptosis in immune cells: potential role for CB2-selective ligands as immunosuppressive agents. Clin. Immunol., 2007, 122, (3), 259-270. (Pubitemid 46216921)
37. Chang, S.L.; Chang, C.L.; Chiang, Y.M.; Hsieh, R.H.; Tzeng, C.R.; Wu, T.K.; Sytwu, H.K.; Shyur, L.F.; Yang, W.C., Polyacetylenic compounds and butanol fraction from Bidens pilosa can modulate the differentiation of helper T cells and prevent autoimmune diabetes in non-obese diabetic mice. Planta Med., 2004, 70, (11), 1045-1051. (Pubitemid 39587038)
38. Chiang, Y.M.; Chang, C.L.; Chang, S.L.; Yang, W.C.; Shyur, L.F., Cytopiloyne, a novel polyacetylenic glucoside from Bidens pilosa, functions as a T helper cell modulator. J. Ethnopharmacol., 2007, 110, (3), 532-538. (Pubitemid 46386358)
39. Mishra, R.; Sellin, D.; Radovan, D.; Gohlke, A.; Winter, R., Inhibiting islet amyloid polypeptide fibril formation by the red wine compound resveratrol. Chembiochem, 2009, 10, (3), 445-449.
40. Ku, C.R.; Lee, H.J.; Kim, S.K.; Lee, E.Y.; Lee, M.K.; Lee, E.J., Resveratrol prevents streptozotocin-induced diabetes by inhibiting the apoptosis of pancreatic beta-cell and the cleavage of poly (ADP-ribose) polymerase. Endocr. J., 2012, 59, (2), 103-109.
41. Falchetti, R.; Fuggetta, M.P.; Lanzilli, G.; Tricarico, M.; Ravagnan, G., Effects of resveratrol on human immune cell function. Life Sci., 2001, 70, (1), 81-96. (Pubitemid 33124357)
42. Feng, Y.H.; Zhou, W.L.; Wu, Q.L.; Li, X.Y.; Zhao, W.M.; Zou, J.P., Low dose of resveratrol enhanced immune response of mice. Acta Pharmacol. Sin., 2002, 23, (10), 893-897.
43. Nevius, E.; Srivastava, P.K.; Basu, S., Oral ingestion of Capsaicin, the pungent component of chili pepper, enhances a discreet population of macrophages and confers protection from autoimmune diabetes. Mucosal Immunol., 2012, 5, (1), 76-86.
44. Islam, M.S.; Choi, H., Dietary red chilli (Capsicum frutescens L.) is insulinotropic rather than hypoglycemic in type 2 diabetes model of rats. Phytother. Res., 2008, 22, (8), 1025-1029.
45. Fujii, M.; Takei, I.; Umezawa, K., Antidiabetic effect of orally administered conophylline-containing plant extract on streptozotocin-Treated and Goto-Kakizaki rats. Biomed. Pharmacother., 2009, 63, (10), 710-716.
46. Sasidharan, S.; Sumathi, V.; Jegathambigai, N.R.; Latha, L.Y., Antihyper glycaemic effects of ethanol extracts of Carica papaya and Pandanus amaryfollius leaf in streptozotocin-induced diabetic mice. Nat. Prod. Res., 2011, 25, (20), 1982-1987.
47. Shen, M.Y.; Liu, Y.J.; Don, M.J.; Liu, H.Y.; Chen, Z.W.; Mettling, C.; Corbeau, P.; Chiang, C.K.; Jang, Y.S.; Li, T.H.; Young, P.; Chang, C.L.; Lin, Y.L.; Yang, W.C., Combined phytochemistry and chemotaxis assays for identification and mechanistic analysis of anti-inflammatory phytochemicals in Fallopia japonica. PLoS One, 2011, 6, (11), e27480.
48. Seifarth, C.; Littmann, L.; Resheq, Y.; Rossner, S.; Goldwich, A.; Pangratz, N.; Kerek, F.; Steinkasserer, A.; Zinser, E., MCS-18, a novel natural plant product prevents autoimmune diabetes. Immunol. Lett., 2011, 139, (1-2), 58-67.
49. Shi, N.W.; Wu, Y.J.; Wang, Y.F., Study on the mechanism of Tripterygium wilfordii in preventing type 1 nonobese diabetic mice. Chin. J. Integrated Trad. Western Med., 2006, 26 Suppl, 79-83.
50. Cvjeticanin, T.; Miljkovic, D.; Stojanovic, I.; Dekanski, D.; Stosic-Grujicic, S., Dried leaf extract of Olea europaea ameliorates islet-directed autoimmunity in mice. Br. J. Nutr., 2010, 103, (10), 1413-1424.
51. Alarcon-Aguilar, F.J.; Fortis-Barrera, A.; Angeles-Mejia, S.; Banderas-Dorantes, T.R.; Jasso-Villagomez, E.I.; Almanza-Perez, J.C.; Blancas-Flores, G.; Zamilpa, A.; Diaz-Flores, M.; Roman-Ramos, R., Anti-inflammatory and antioxidant effects of a hypoglycemic fructan fraction from Psacalium peltatum (H.B.K.) Cass. in streptozotocin-induced diabetes mice. J. Ethnopharmacol., 2010, 132, (2), 400-407.
52. Chang, C.L.; Kuo, H.K.; Chang, S.L.; Chiang, Y.M.; Lee, T.H.; Wu, W.M.; Shyur, L.F.; Yang, W.C., The distinct effects of a butanol fraction of Bidens pilosa plant extract on the development of Th1-mediated diabetes and Th2-mediated airway inflammation in mice. J. Biomed. Sci., 2005, 12, (1), 79-89. (Pubitemid 40576766)
53. Han, J.; Lin, H.; Huang, W., Modulating gut microbiota as an anti-diabetic mechanism of berberine. Med. Sci. Monit., 2011, 17, (7), RA164-167.
54. Vuddanda, P.R.; Chakraborty, S.; Singh, S., Berberine: a potential phyto chemical with multispectrum therapeutic activities. Expert Opin. Investig. Drugs, 2010, 19, (10), 1297-1307.
55. Kulkarni, S.K.; Dhir, A., Berberine: a plant alkaloid with therapeutic potential for central nervous system disorders. Phytother. Res., 2010, 24, (3), 317-324.
56. Imanshahidi, M.; Hosseinzadeh, H., Pharmacological and therapeutic effects of Berberis vulgaris and its active constituent, berberine. Phytother. Res., 2008, 22, (8), 999-1012.
57. Lau, C.W.; Yao, X.Q.; Chen, Z.Y.; Ko, W.H.; Huang, Y., Cardiovascular actions of berberine. Cardiovasc. Drug Rev., 2001, 19, (3), 234-244. (Pubitemid 34019907)
58. Sabu, M.C.; Smitha, K.; Kuttan, R., Anti-diabetic activity of green tea polyphenols and their role in reducing oxidative stress in experimental diabetes. J. Ethnopharmacol., 2002, 83, (1-2), 109-116. (Pubitemid 36164734)
59. Hayashino, Y.; Fukuhara, S.; Okamura, T.; Tanaka, T.; Ueshima, H., High oolong tea consumption predicts future risk of diabetes among Japanese male workers: a prospective cohort study. Diabet. Med., 2011, 28, (7), 805-810.
60. Fu, Z.; Zhen, W.; Yuskavage, J.; Liu, D., Epigallocatechin gallate delays the onset of type 1 diabetes in spontaneous non-obese diabetic mice. Br. J. Nutr., 2011, 105, (8), 1218-1225.
61. Virtanen, S.M.; Rasanen, L.; Aro, A.; Ylonen, K.; Lounamaa, R.; Akerblom, H.K.; Tuomilehto, J., Is children's or parents' coffee or tea consumption associated with the risk for type 1 diabetes mellitus in children? Childhood Diabetes in Finland Study Group. Eur. J. Clin. Nutr., 1994, 48, (4), 279-285. (Pubitemid 24123698)
62. Kodera, T.; Yamada, S.; Yamamoto, Y.; Hara, A.; Tanaka, Y.; Seno, M.; Umezawa, K.; Takei, I.; Kojima, I., Administration of conophylline and betacellulin-delta4 increases the beta-cell mass in neonatal streptozotocintreated rats. Endocr. J., 2009, 56, (6), 799-806.
63. Rao, I.M.; Arulanantham, A.R.; Terry, N., Leaf Phosphate Status, Photosynthesis and Carbon Partitioning in Sugar Beet: II. Diurnal Changes in Sugar Phosphates, Adenylates, and Nicotinamide Nucleotides. Plant Physiol., 1989, 90, (3), 820-826.
64. Beran, M.; Stahl, R.; Beran, M., Jr., Glycaemic activity of (III)-betanicotinamide adenine dinucleotide phoshate complex and its presence in yeast extracts. Analyst, 1995, 120, (3), 979-981.
65. Sandler, S.; Hellerstrom, C.; Eizirk, D.L., Effects of nicotinamide supplementation on human pancreatic islet function in tissue culture. J. Clin. Endocrinol. Metab., 1993, 77, (6), 1574-1576. (Pubitemid 24000916)
66. Kim, J.Y.; Chi, J.K.; Kim, E.J.; Park, S.Y.; Kim, Y.W.; Lee, S.K., Inhibition of diabetes in non-obese diabetic mice by nicotinamide treatment for 5 weeks at the early age. J. Kor. Med. Sci., 1997, 12, (4), 293-297.
67. Crino, A.; Schiaffini, R.; Ciampalini, P.; Suraci, M.C.; Manfrini, S.; Visalli, N.; Matteoli, M.C.; Patera, P.; Buzzetti, R.; Guglielmi, C.; Spera, S.; Costanza, F.; Fioriti, E.; Pitocco, D.; Pozzilli, P., A two year observational study of nicotinamide and intensive insulin therapy in patients with recent onset type 1 diabetes mellitus. J. Pediatr. Endocrinol. Metab., 2005, 18, (8), 749-754. (Pubitemid 41309337)
68. Visalli, N.; Cavallo, M.G.; Signore, A.; Baroni, M.G.; Buzzetti, R.; Fioriti, E.; Mesturino, C.; Fiori, R.; Lucentini, L.; Matteoli, M.C.; Crino, A.; Corbi, S.; Spera, S.; Teodonio, C.; Paci, F.; Amoretti, R.; Pisano, L.; Suraci, C.; Multari, G.; Sulli, N.; Cervoni, M.; De Mattia, G.; Faldetta, M.R.; Boscherini, B.; Pozzilli, P.; et al., A multi-centre randomized trial of two different doses of nicotinamide in patients with recent-onset type 1 diabetes (the IMDIAB VI). Diabetes Metab. Res. Rev., 1999, 15, (3), 181-185. (Pubitemid 29359035)
69. Rui, Y.C., Advances in pharmacological studies of silymarin. Mem. Inst. Oswaldo Cruz, 1991, 86 Suppl 2, 79-85.
70. Huseini, H.F.; Larijani, B.; Heshmat, R.; Fakhrzadeh, H.; Radjabipour, B.; Toliat, T.; Raza, M., The efficacy of Silybum marianum (L.) Gaertn. (silymarin) in the treatment of type II diabetes: a randomized, double-blind, placebo-controlled, clinical trial. Phytother. Res., 2006, 20, (12), 1036-1039. (Pubitemid 44951705)
71. Hussain, S.A., Silymarin as an adjunct to glibenclamide therapy improves long-Term and postprandial glycemic control and body mass index in type 2 diabetes. J. Med. Food, 2007, 10, (3), 543-547. (Pubitemid 47493502)
72. Jose, M.A.; Abraham, A.; Narmadha, M.P., Effect of silymarin in diabetes mellitus patients with liver diseases. J. Pharmacol. Pharmacother., 2011, 2, (4), 287-289.
73. Soto, C.; Mena, R.; Luna, J.; Cerbon, M.; Larrieta, E.; Vital, P.; Uria, E.; Sanchez, M.; Recoba, R.; Barron, H.; Favari, L.; Lara, A., Silymarin induces recovery of pancreatic function after alloxan damage in rats. Life Sci., 2004, 75, (18), 2167-2180. (Pubitemid 39120024)
74. Soto, C.; Perez, J.; Garcia, V.; Uria, E.; Vadillo, M.; Raya, L., Effect of silymarin on kidneys of rats suffering from alloxan-induced diabetes mellitus. Phytomedicine, 2010, 17, (14), 1090-1094.
75. Soto, C.; Recoba, R.; Barron, H.; Alvarez, C.; Favari, L., Silymarin increases antioxidant enzymes in alloxan-induced diabetes in rat pancreas. Comp. Biochem. Physiol. C Toxicol. Pharmacol., 2003, 136, (3), 205-212. (Pubitemid 37500850)
76. Soto, C.P.; Perez, B.L.; Favari, L.P.; Reyes, J.L., Prevention of alloxaninduced diabetes mellitus in the rat by silymarin. Comp. Biochem. Physiol. C Pharmacol. Toxicol. Endocrinol., 1998, 119, (2), 125-129. (Pubitemid 28221648)
77. Srivastava, R.K.; Sharma, S.; Verma, S.; Arora, B.; Lal, H., Influence of diabetes on liver injury induced by antitubercular drugs and on silymarin hepatoprotection in rats. Methods Find. Exp. Clin. Pharmacol., 2008, 30, (10), 731-737.
78. Vengerovskii, A.I.; Khazanov, V.A.; Eskina, K.A.; Vasilyev, K.Y., Effects of silymarin (hepatoprotector) and succinic acid (bioenergy regulator) on metabolic disorders in experimental diabetes mellitus. Bull. Exp. Biol. Med., 2007, 144, (1), 53-56. (Pubitemid 350142485)
79. Lin, S.Y.; Lai, W.W.; Ho, C.C.; Yu, F.S.; Chen, G.W.; Yang, J.S.; Liu, K.C.; Lin, M.L.; Wu, P.P.; Fan, M.J.; Chung, J.G., Emodin induces apoptosis of human tongue squamous cancer SCC-4 cells through reactive oxygen species and mitochondria-dependent pathways. Anticancer Res., 2009, 29, (1), 327-335.
80. Chang, L.C.; Sheu, H.M.; Huang, Y.S.; Tsai, T.R.; Kuo, K.W., A novel function of emodin: enhancement of the nucleotide excision repair of UVand cisplatin-induced DNA damage in human cells. Biochem. Pharmacol., 1999, 58, (1), 49-57.
81. Ding, Y.; Zhao, L.; Mei, H.; Zhang, S.L.; Huang, Z.H.; Duan, Y.Y.; Ye, P., Exploration of Emodin to treat alpha-naphthylisothiocyanate-induced cholestatic hepatitis via anti-inflammatory pathway. Eur. J. Pharmacol., 2008, 590, (1-3), 377-386.
82. Matsuda, H.; Shimoda, H.; Morikawa, T.; Yoshikawa, M., Phytoestrogens from the roots of Polygonum cuspidatum (Polygonaceae): structurerequirement of hydroxyanthraquinones for estrogenic activity. Bioorg. Med. Chem. Lett., 2001, 11, (14), 1839-1842. (Pubitemid 32675300)
83. Nguyen, M.; Dougados, M.; Berdah, L.; Amor, B., Diacerhein in the treatment of osteoarthritis of the hip. Arthritis Rheum., 1994, 37, (4), 529-536. (Pubitemid 24115939)
84. Malaguti, C.; Vilella, C.A.; Vieira, K.P.; Souza, G.H.; Hyslop, S.; Zollner Rde, L., Diacerhein downregulate proinflammatory cytokines expression and decrease the autoimmune diabetes frequency in nonobese diabetic (NOD) mice. Int. Immunopharmacol., 2008, 8, (6), 782-791.
85. Pertwee, R.G., Pharmacology of cannabinoid CB1 and CB2 receptors. Pharmacol. Ther., 1997, 74, (2), 129-180. (Pubitemid 27337346)
86. Weiss, L.; Zeira, M.; Reich, S.; Har-Noy, M.; Mechoulam, R.; Slavin, S.; Gallily, R., Cannabidiol lowers incidence of diabetes in non-obese diabetic mice. Autoimmunity, 2006, 39, (2), 143-151. (Pubitemid 43675258)
87. Weiss, L.; Zeira, M.; Reich, S.; Slavin, S.; Raz, I.; Mechoulam, R.; Gallily, R., Cannabidiol arrests onset of autoimmune diabetes in NOD mice. Neuropharmacology, 2008, 54, (1), 244-249. (Pubitemid 350299408)
88. Yin, B.; Ma, G.; Yen, C.Y.; Zhou, Z.; Wang, G.X.; Divino, C.M.; Casares, S.; Chen, S.H.; Yang, W.C.; Pan, P.Y., Myeloid-derived suppressor cells prevent type 1 diabetes in murine models. J. Immunol., 2010, 185, (10), 5828-5834.
89. Hu, C.; Du, W.; Zhang, X.; Wong, F.S.; Wen, L., The role of Gr1+ cells after anti-CD20 treatment in type 1 diabetes in nonobese diabetic mice. J. Immunol., 2012, 188, (1), 294-301.
90. Chen, W.; Li, Y.M.; Yu, M.H., Astragalus polysaccharides: an effective treatment for diabetes prevention in NOD mice. Exp. Clin. Endocrinol. Diabetes, 2008, 116, (8), 468-474.
91. Meng, H.T.; Zhu, L.; Ni, W.M.; You, L.S.; Jin, J.; Qian, W.B., Triptolide inhibits the proliferation of cells from lymphocytic leukemic cell lines in association with downregulation of NF-kappaB activity and miR-16-1. Acta Pharmacol. Sin., 2011, 32, (4), 503-511.
92. Wang, X.; Matta, R.; Shen, G.; Nelin, L.D.; Pei, D.; Liu, Y., Mechanism of triptolide-induced apoptosis: Effect on caspase activation and Bid cleavage and essentiality of the hydroxyl group of triptolide. J. Mol. Med (Berl.), 2006, 84, (5), 405-415. (Pubitemid 43673615)
93. Yang, Y.; Liu, Z.; Tolosa, E.; Yang, J.; Li, L., Triptolide induces apoptotic death of T lymphocyte. Immunopharmacology, 1998, 40, (2), 139-149. (Pubitemid 28439168)
94. Hsu, Y.J.; Lee, T.H.; Chang, C.L.; Huang, Y.T.; Yang, W.C., Antihyperglycemic effects and mechanism of Bidens pilosa water extract. J. Ethnopharmacol., 2009, 122, (2), 379-383.
95. Chien, S.C.; Young, P.H.; Hsu, Y.J.; Chen, C.H.; Tien, Y.J.; Shiu, S.Y.; Li, T.H.; Yang, C.W.; Marimuthu, P.; Tsai, L.F.; Yang, W.C., Anti-diabetic properties of three common Bidens pilosa variants in Taiwan. Phyto chemistry, 2009, 70, (10), 1246-1254.
96. Chang, C.T.L.; Chang, S.L.; Lee, Y.M.; Chiang, Y.M.; Chuang, D.Y.; Kuo, H.K.; Yang, W.C., Cytopiloyne, a polyacetylenic plucoside, prevents type 1 diabetes in non-obese diabetic mice. J. Immunol., 2007.
97. Aribal-Kocaturk, P.; Kavas, G.O.; Buyukkagnici, D.I., Pretreatment effect of resveratrol on streptozotocin-induced diabetes in rats. Biol. Trace Elem. Res., 2007, 118, (3), 244-249. (Pubitemid 47556622)
98. Lee, S.M.; Yang, H.; Tartar, D.M.; Gao, B.; Luo, X.; Ye, S.Q.; Zaghouani, H.; Fang, D., Prevention and treatment of diabetes with resveratrol in a nonobese mouse model of type 1 diabetes. Diabetologia, 2011, 54, (5), 1136-1146.
99. Vetterli, L.; Brun, T.; Giovannoni, L.; Bosco, D.; Maechler, P., Resveratrol potentiates glucose-stimulated insulin secretion in INS-1E beta-cells and human islets through a SIRT1-dependent mechanism. J. Biol. Chem., 2011, 286, (8), 6049-6060.
100. Pacholec, M.; Bleasdale, J.E.; Chrunyk, B.; Cunningham, D.; Flynn, D.; Garofalo, R.S.; Griffith, D.; Griffor, M.; Loulakis, P.; Pabst, B.; Qiu, X.; Stockman, B.; Thanabal, V.; Varghese, A.; Ward, J.; Withka, J.; Ahn, K., SRT1720, SRT2183, SRT1460, and resveratrol are not direct activators of SIRT1. J. Biol. Chem., 2010, 285, (11), 8340-8351.
101. Haigis, M.C.; Sinclair, D.A., Mammalian sirtuins: biological insights and disease relevance. Annu. Rev. Pathol., 2010, 5, 253-295.
102. Sharma, S.; Chopra, K.; Kulkarni, S.K.; Agrewala, J.N., Resveratrol and curcumin suppress immune response through CD28/CTLA-4 and CD80 costimulatory pathway. Clin. Exp. Immunol., 2007, 147, (1), 155-163. (Pubitemid 44915567)
103. Svajger, U.; Jeras, M., Anti-inflammatory Effects of resveratrol and its potential use in therapy of immune-mediated diseases. Int. Rev. Immunol., 2012, 31, (3), 202-222.
104. Li, C.R.; Baaten, B.J.; Bradley, L.M., Harnessing memory adaptive regulatory T cells to control autoimmunity in type 1 diabetes. J. Mol. Cell. Biol., 2012, 4, (1), 38-47.
105. Bresson, D.; von Herrath, M., Moving towards efficient therapies in type 1 diabetes: to combine or not to combine? Autoimmun. Rev., 2007, 6, (5), 315-322. (Pubitemid 46507996)
106. Law, S.K.; Simmons, M.P.; Techen, N.; Khan, I.A.; He, M.F.; Shaw, P.C.; But, P.P., Molecular analyses of the Chinese herb Leigongteng (Tripterygium wilfordii Hook.f.). Phytochemistry, 2011, 72, (1), 21-26.